{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:38:31Z","timestamp":1790663911821,"version":"4.1.0"},"reference-count":74,"publisher":"American Chemical Society (ACS)","issue":"23","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018536","name":"NuCana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018536","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2022,12,8]]},"DOI":"10.1021\/acs.jmedchem.2c01348","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T16:51:16Z","timestamp":1669222276000},"page":"15789-15804","source":"Crossref","is-referenced-by-count":23,"title":["Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3\u2032-Deoxyadenosine, as a Potential Anticancer Agent"],"prefix":"10.1021","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-7910","authenticated-orcid":true,"given":"Michaela","family":"Serpi","sequence":"first","affiliation":[{"name":"School of Chemistry, Cardiff University Main Building, Park Place, Cardiff CF10 3AT, Wales, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ferrari","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, King Edward VII Avenue, Cardiff CF10 3NB, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McGuigan","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, King Edward VII Avenue, Cardiff CF10 3NB, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essam","family":"Ghazaly","sequence":"additional","affiliation":[{"name":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Pepper","sequence":"additional","affiliation":[{"name":"Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9PX, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2008.01.027"},{"key":"ref2\/cit2","first-page":"572","volume":"6","author":"Tah J.","year":"2017","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.09.030"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-013-0121-9"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.2174\/18763960010030100179"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2014.09.001"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103027"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24122231"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.6b00209"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1261\/rna.1458909"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/jf100269g"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90046-0"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.121"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21101267"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/0926-6569(64)90072-0"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150712778"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.03.010"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317706915"},{"key":"ref19\/cit19","first-page":"43","volume":"26","author":"Nakamura K.","year":"2006","journal-title":"Anticancer Res."},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.07.068"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.etap.2014.06.003"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10070240"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2020.01.004"},{"key":"ref24\/cit24","unstructured":"Boston Medical Center. A Phase I Study of Cordycepin (NSC 63984) Plus 2\u2032-Deoxycoformycin\n(NSC 218321) in Patients With Refractory TdT-Positive Leukemia In: ClinicalTrials.gov [internet] National Library of Medicine [cited\n2022 March 31] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00709215. NLM identifier: NCT00709215."},{"key":"ref25\/cit25","unstructured":"Boston Medical Center. Chemotherapy\nWith Cordycepin Plus Pentostatin in Treating Patients\nWith Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia In: ClinicalTrials.gov [internet] National Library of Medicine [cited\n2022 March 31] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00003005. NLM identifier: NCT00003005."},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2021.1922385"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1177\/2040206618775243"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.142464"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.11.009"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1021\/jm401853a"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0244-1"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1021\/jm200815w"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1652"},{"key":"ref35\/cit35","unstructured":"University of Oxford. NUC-3373\nin Advanced Solid Tumours (NuTide:301).\nIn: ClinicalTrials.gov [internet] National Library of Medicine [cited\n2022 March 31] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02723240. NLM identifier: NCT02723240."},{"key":"ref36\/cit36","unstructured":"NuCana plc. A Safety\nStudy of NUC-3373 in Combination With Standard Agents Used in Colorectal\nCancer Treatment In: ClinicalTrials.gov [internet]\nNational Library of Medicine [cited 2022 March 31] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03428958. NLM identifier: NCT03428958."},{"key":"ref37\/cit37","unstructured":"Imperial College London. NUC-1031\nin Patients With Advanced Solid Tumours (ProGem1) In:\nClinicalTrials.gov [internet] National Library of Medicine [cited\n2022 March 31] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01621854. NLM identifier: NCT01621854."},{"key":"ref38\/cit38","unstructured":"NuCana plc. NUC-1031\nof Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian\nCancer (ProGem2) In: ClinicalTrials.gov [internet]\nNational Library of Medicine [cited 2022 March 31] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02303912. NLM identifier NCT02303912."},{"key":"ref39\/cit39","unstructured":"NuCana plc. NUC-1031\nin Patients With Platinum-Resistant Ovarian Cancer. In: ClinicalTrials.gov [internet] National Library of Medicine\n[cited 2022 March 31] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03146663. NLM identifier: NCT03146663."},{"key":"ref40\/cit40","unstructured":"The Christie NHS Foundation Trust. ABC-08: Phase Ib Trial of Acelarin in Combination\nwith Cisplatin in Locally Advanced\/ Metastatic Biliary Tract Cancers\n(ABC-08). In: ClinicalTrials.gov [internet] National\nLibrary of Medicine [cited 2022 March 31] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02351765. NLM identifier: NCT 02351765."},{"key":"ref41\/cit41","unstructured":"NuCana plc. A Safety\nStudy of NUC-7738 in Patients With Advanced Solid Tumours or Lymphoma. In: ClinicalTrials.gov [internet] National Library of Medicine\n[cited 2022 March 31] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03829254. NLM identifier: NCT03829254."},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1021\/ja01068a049"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1021\/ja960581l"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1021\/ja00412a034"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.1021\/jo0003652"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.1039\/JR9600003275"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(00)98716-1"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1055\/s-1991-20686"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1021\/op000209x"},{"key":"ref50\/cit50","doi-asserted-by":"publisher","DOI":"10.1021\/jm401497a"},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1002\/0471142700.nc1505s53"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1021\/jm100863x"},{"key":"ref53\/cit53","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002338"},{"key":"ref54\/cit54","doi-asserted-by":"publisher","DOI":"10.1021\/jm400201a"},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.056135"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2670(00)01369-6"},{"key":"ref57\/cit57","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(02)01738-7"},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1021\/jo201492m"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC00448A"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.201100614"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7936"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02194"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201800504"},{"key":"ref64\/cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.09.047"},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1002\/0471142700.nc1506s60"},{"key":"ref66\/cit66","doi-asserted-by":"crossref","unstructured":"Surburg, H.; Panten, J.\n                      Common Fragrance and Flavor Materials: Preparation, Properties and Uses\n                      . 6th ed. Hoboken, NJ, 2016.","DOI":"10.1002\/9783527693153"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401903"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.05.005"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.3390\/mps2030060"},{"key":"ref70\/cit70","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23258"},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1021\/jm1003792"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1021\/jm9007856"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.57.316"},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1080\/15257770701521656"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.2c01348","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.2c01348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T19:22:54Z","timestamp":1682623374000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.2c01348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":74,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022,12,8]]}},"alternative-id":["10.1021\/acs.jmedchem.2c01348"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.2c01348","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}